Human C-C Chemokine Receptor Type 7 (CCR7) Protein

Product specifications

Proteins and Peptides

C-C Chemokine Receptor Type 7 (CCR7)

E. coli

Activity: Not tested
Sequence Fragment: Asn290-Pro378
Tag: N-terminal His tag

Human

Unconjugated

Calculated MW: 13.5 kDa  Observed MW (SDS-PAGE): 16 kDa

Recombinant

> 90%

10 µg

50 µg

100 µg

200 µg

500 µg

Lyophilized

WB, SDS-PAGE

Prior to lyophilization: PBS, pH 7.4, containing 0.01% Sarcosyl, 1 mM DTT, 5% Trehalose and Proclin-300.

Shipped within 5-7 working days.

Store lyophilized form at 2-8°C for up to 1 month. For longer periods, store lyophilized or liquid at -80°C. Avoid repeated freeze–thaw cycles.

No

CCR7,C-C motif chemokine receptor 7,BLR2,CC-CKR-7,CCR-7,CD197,CDw197,CMKBR7,EBI,1

Protein CCR7

RUO

THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
To keep the original salt concentration, we recommend reconstituting to the original concentration prior to lyophilization (see Concentration) in ddH2O. If a lower concentration is required, dilute in PBS, pH 7.4. If a higher concentration is required, the product can be reconstituted directly in PBS, pH 7.4, though please note that this will change the overall salt concentration. The stock concentration should be between 0.1-1.0 mg/ml. Do not vortex.
Concentration: Prior to lyophilization: 200 µg/ml

Descripción

C-C Chemokine Receptor Type 7 (CCR7) is a G-protein-coupled receptor (GPCR) expressed on naïve T cells, central memory T cells, dendritic cells, and B cells, playing a central role in immune surveillance and lymphocyte trafficking. CCR7 interacts with its ligands CCL19 and CCL21, which are expressed in secondary lymphoid organs, such as lymph nodes and spleen. This receptor directs homing of lymphocytes and dendritic cells to the lymph nodes, enabling efficient antigen presentation, T-cell activation, and adaptive immune responses. CCR7 is critical for lymphocyte recirculation, guiding naïve T cells from the bloodstream into the lymph nodes where they encounter antigens presented by dendritic cells. In the context of cancer, CCR7 is overexpressed on tumor cells in cancers like breast cancer, gastric cancer, and chronic lymphocytic leukemia (CLL), facilitating lymph node metastasis through chemotactic signaling. Additionally, CCR7 promotes T-cell positioning within the thymus, playing a key role in T-cell development and immune tolerance. Dysregulation of CCR7 signaling is associated with autoimmune diseases, including rheumatoid arthritis and multiple sclerosis, where improper lymphocyte migration contributes to chronic inflammation. Given its role in immune regulation, CCR7 has emerged as a promising therapeutic target in cancer immunotherapy and autoimmune disease treatment, where modulating its activity could restore immune homeostasis or inhibit metastasis.

Related Products

APC Anti-Human CD197 Antibody(G043H7)

Ver Producto

Human CCR7 (C-C chemokine receptor type 7) ELISA Kit

Ver Producto

FITC Anti-Human CD197 Antibody(G043H7)

Ver Producto